278 related articles for article (PubMed ID: 21724679)
21. [Bisphosphonates in malignant hypercalcemia and bone pain].
Lamy O
Rev Med Suisse Romande; 2004 Feb; 124(2):111-4. PubMed ID: 15095627
[TBL] [Abstract][Full Text] [Related]
22. Newer agents for the treatment of malignant hypercalcemia.
Kinirons MT
Am J Med Sci; 1993 Jun; 305(6):403-6. PubMed ID: 8506902
[TBL] [Abstract][Full Text] [Related]
23. The management of malignant hypercalcaemia.
Watters J; Gerrand G; Dodwell D
Drugs; 1996 Dec; 52(6):837-48. PubMed ID: 8957154
[TBL] [Abstract][Full Text] [Related]
24. Acute management of cancer-related hypercalcemia.
Chisholm MA; Mulloy AL; Taylor AT
Ann Pharmacother; 1996 May; 30(5):507-13. PubMed ID: 8740333
[TBL] [Abstract][Full Text] [Related]
25. Hypercalcemia.
Bilezikian JP
Curr Ther Endocrinol Metab; 1994; 5():511-4. PubMed ID: 7704784
[No Abstract] [Full Text] [Related]
26. [Medical treatment of malignant hypercalcemia].
Eto S; Nakano Y; Okada Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
[TBL] [Abstract][Full Text] [Related]
27. Drug therapy of hypercalcemia due to malignancy.
Raue F; Pecherstorfer M
Recent Results Cancer Res; 1994; 137():138-60. PubMed ID: 7878293
[No Abstract] [Full Text] [Related]
28. Pathogenesis and management of cancer associated hypercalcaemia.
Ralston SH
Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
[TBL] [Abstract][Full Text] [Related]
29. [Progress in diagnosis and therapy: Hypercalcemia due to multiple myeloma and wide-spread neoplastic bone metastasis].
Abe M
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):675-80. PubMed ID: 17506303
[No Abstract] [Full Text] [Related]
30. [Hypercalcemia in malignancy].
Eto S
Rinsho Byori; 1994 Sep; 42(9):943-51. PubMed ID: 7967119
[TBL] [Abstract][Full Text] [Related]
31. Systemic lupus erythematosus and hypercalcaemia: case report and brief review of the literature.
Karageorgas TP; Avgoustidis N; Ioakeimidis D
Scand J Rheumatol; 2011; 40(5):408-9. PubMed ID: 21916802
[No Abstract] [Full Text] [Related]
32. Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
Leyland-Jones B
Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255
[TBL] [Abstract][Full Text] [Related]
33. Mismanagement of malignant hypercalcaemia.
Lightowlers S; Patterson D
Clin Med (Lond); 2013 Feb; 13(1):118. PubMed ID: 23472518
[No Abstract] [Full Text] [Related]
34. [Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].
Tomoo T; Suzuki M
Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):353-7. PubMed ID: 16394581
[No Abstract] [Full Text] [Related]
35. Treatment of hypercalcemia of malignancy with bisphosphonates.
Berenson JR
Semin Oncol; 2002 Dec; 29(6 Suppl 21):12-8. PubMed ID: 12584690
[TBL] [Abstract][Full Text] [Related]
36. Hypercalcemia and gallium nitrate.
Harvey HA; Almokadem SM
J Support Oncol; 2004; 2(6):516-7. PubMed ID: 16329217
[No Abstract] [Full Text] [Related]
37. [Hypercalcemia (with treatment)].
PriƩ D
Rev Prat; 2006 Oct; 56(16):1827-33. PubMed ID: 17315511
[No Abstract] [Full Text] [Related]
38. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.
Lin PH; Chiu CF; Lu YS
Ann Oncol; 2011 May; 22(5):1244-1246. PubMed ID: 21460375
[No Abstract] [Full Text] [Related]
40. Treatment of malignant hypercalcaemia.
Hurtado J; Esbrit P
Expert Opin Pharmacother; 2002 May; 3(5):521-7. PubMed ID: 11996631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]